+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 1Day - 90Days
All Genders
ID07045844

Comparing Pasteurized Donor Milk and Preterm Formula Supplementation and Fortification Strategies in Very Preterm Infants to Reduce Necrotizing Enterocolitis and Improve Development

Led by The Children's Hospital of Zhejiang University School of Medicine · Updated on 2026-10-26

2324

Participants Needed

24

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether supplementing very preterm infants born before 29 weeks of gestation with pasteurized donor human milk pHDM or preterm formula PTF when their own mothers milk OMM is insufficient can improve survival without surgery-requiring necrotizing enterocolitis NEC by 34 weeks corrected gestational age. The study also assesses if routine use of human milk fortifiers is better than selective use based on growth faltering. This trial is a multicenter, double-randomized, open-label trial conducted alongside routine neonatal care, aimed at improving both short- and long-term outcomes in this vulnerable population. Participants will be randomized twice first, within the first week of life to receive either pHDM or PTF as supplemental feeding if OMM is insufficient second, during the second week of life to receive either routine fortification of human milk or selective fortification only if growth faltering occurs. Feeding and care follow standard clinical practice throughout the study. Two groups are compared to determine which supplement and fortification strategy better supports survival and neurodevelopment. During the study, participants will undergo feeding and care according to routine practice, with neurodevelopmental assessments performed at 2 years corrected age using the Griffiths Mental Development Scales. Researchers will measure survival without surgical NEC at 34 weeks corrected age as the primary outcome, along with various secondary outcomes including survival during hospitalization, NEC incidence, infections, growth parameters, and brain injury. The study continues until the infants reach 2 years corrected age to assess long-term development and health.

CONDITIONS

Brief Title

Effects of Enteral Feeding Regimens on NEC, Mortality, and Neurodevelopment in Very Preterm Infants

Research Team

Y

Yanping Xu

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here